Skip to main content
Clinical Trials/NCT05841368
NCT05841368
Not yet recruiting
Not Applicable

DELIRIUM SCREENING, INCIDENCE AND MANAGEMENT OBSERVATIONAL STUDY IN 2024 - THE CZECH REPUBLIC

Brno University Hospital1 site in 1 country2,000 target enrollmentJanuary 1, 2024
ConditionsDelirium

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Delirium
Sponsor
Brno University Hospital
Enrollment
2000
Locations
1
Primary Endpoint
Delirium prevalence
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

Delirium in intensive care unit (ICU) settings is a frequent complication with reported prevalence of 31%. Recent data has revealed the connection between delirium and increased 30days mortality after hospital release and the higher incidence of readmission to emergency. Despite the high prevalence and well described validation methods for screening, the precise incidence remains unclear due to insufficient screening in ICU settings. The incidence of delirium in Czech Republic remains undescribed, beside data reported from neurointensive care patients and single-center general critically ill patients data.

Detailed Description

All patients fulfilling inclusion criteria in intensive care settings in involved ICUs in Czech Republic will be included into the study. Data will be recorded for 1 consequent month. Basic demography will be evaluated. In each patient standard delirium screening based on the institutional ICU rules will be performed. If no screening method were set,Confusion Assessment Method - CAM-ICU for adult and pediatric Confusion Assessment Method -pCAM-ICU for pediatric patients would be used together with delirium management, restrain procedures, sedative/neuroleptics administration, 28-days mortality. All data will be recorded into to predefined eCRF.

Registry
clinicaltrials.gov
Start Date
January 1, 2024
End Date
July 31, 2024
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Brno University Hospital
Responsible Party
Principal Investigator
Principal Investigator

Petr Štourač, MD

Clinical Professor

Brno University Hospital

Eligibility Criteria

Inclusion Criteria

  • Patients in ICU settings
  • in defined time interval of the study

Exclusion Criteria

  • duration of ICU stay shorter than 24 hours

Outcomes

Primary Outcomes

Delirium prevalence

Time Frame: during 30 days after study initiation in selected ICU

Delirium prevalence by CAM-ICU and pCAM-ICU will be screened in defined time interval

Secondary Outcomes

  • Delirium management(during 30 days after study initiation in selected ICU)
  • 90-days mortality(after patient inclusion into the study)
  • Inhospital mortality(during 30 days after study initiation in selected ICU)
  • 28-days mortality(after patient inclusion into the study)

Study Sites (1)

Loading locations...

Similar Trials